These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 13527242)

  • 21. The clinical evaluation of serum glutamic oxaloacetic transaminase activity.
    HOEVENAARS HA; OVERHOLT BM
    J Tn State Med Assoc; 1957 Mar; 50(3):95-101. PubMed ID: 13406834
    [No Abstract]   [Full Text] [Related]  

  • 22. [Determination of blood glutamic oxalacetic transaminase in liver diseases].
    HUBL P; WEWALKA F
    Wien Z Inn Med; 1958 Oct; 39(10):424-32. PubMed ID: 13616391
    [No Abstract]   [Full Text] [Related]  

  • 23. Diagnostic & prognostic significance of blood glutamic oxalacetic transaminase in liver diseases.
    NEUMAYR A; PIETSCHMANN H
    Wien Z Inn Med; 1959 May; 40(5):161-72. PubMed ID: 13676547
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum transaminases in liver diseases.
    DE MAESTRI C; BARBERIO G; GOFFRINI M
    Boll Soc Med Chir Cremona; 1958; 12(3):153-63. PubMed ID: 13572676
    [No Abstract]   [Full Text] [Related]  

  • 25. [Variations in transaminase activity of the blood in liver diseases in humans: clinical reports and pathogenetic mechanism].
    FERRARI V
    Arch Sci Med (Torino); 1957 Aug; 104(2):176-99. PubMed ID: 13471274
    [No Abstract]   [Full Text] [Related]  

  • 26. [Iron binding capacity of the blood serum in acute and chronic diseases of the liver and biliary tract].
    LANGE J; OBERHOFFER G
    Dtsch Arch Klin Med; 1958; 204(6):697-707. PubMed ID: 13547899
    [No Abstract]   [Full Text] [Related]  

  • 27. [Changes in serum transaminases and aldolase during liver diseases].
    SCHWARZMANN V
    Arch Mal Appar Dig Mal Nutr; 1957; 46(1-2):11-22. PubMed ID: 13412224
    [No Abstract]   [Full Text] [Related]  

  • 28. [Serum transaminases and their clinical importance. I. In heart and liver diseases].
    BRUYET P; MEIGNIEN-GAUTHIER C; DELAUNAY A
    Presse Med (1893); 1958 Dec; 66(92):2113 passim. PubMed ID: 13623759
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical importance of serum haptoglobin determination in liver and biliary tract diseases].
    Liakishev AA
    Ter Arkh; 1967 Aug; 39(8):32-7. PubMed ID: 5615298
    [No Abstract]   [Full Text] [Related]  

  • 30. [Serum glutamic-oxalacetic transaminase activity and its clinical significance in diseases of the heart, liver, brain, muscle and in other disease].
    CHIANG SC; HSIAO ST; WANG C
    Zhonghua Nei Ke Za Zhi; 1958 Sep; 6(9):869-72; English abstract 101. PubMed ID: 13608726
    [No Abstract]   [Full Text] [Related]  

  • 31. [Relation between transaminase activity of the blood & histological picture of the liver in human hepatic pathology].
    ORABONA ML; FILOTICO M; MICELLI O
    Minerva Med; 1958 Nov; 49(93):4292-5. PubMed ID: 13613033
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative studies on the clinical value of serum quinineoxidase, transaminase and sorbitoldehydrogenase determination for the demonstration of liver damage in biliary calculosis.
    Genov D; Milev M
    Nauchni Tr Vissh Med Inst Sofiia; 1969; 48(2):7-12. PubMed ID: 4245256
    [No Abstract]   [Full Text] [Related]  

  • 33. [Value of determination of serum transaminases & lactic acid dehydrogenase in liver diseases].
    HORN HD; AMELUNG D
    Dtsch Med Wochenschr; 1957 Apr; 82(17):619-26. PubMed ID: 13437780
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical significance of changes in serum transaminases in liver diseases and coronary disorders].
    RUIZ REYES G; AGUILERA CUENCA R; SUAREZ PUERTO AM
    Medicina (Mex); 1958 Sep; 39(803):401-9. PubMed ID: 13589449
    [No Abstract]   [Full Text] [Related]  

  • 35. [Importance of the determination of serum transaminases in hepatic diseases].
    PAYSANT P; CHANTECLAIR G; LASCOMBES G; GASSE D; DUC M
    Rev Med Nancy; 1960 Dec; 85():1005-27. PubMed ID: 13733709
    [No Abstract]   [Full Text] [Related]  

  • 36. [The isolated and perfused liver. Observations on its morpho-functional changes in the study of biochemical and biological syndromes].
    Civardi F; Tenconi L; Procaccia S; Negri S; Santambrogio C
    Minerva Med; 1969 May; 60(42):2087-91. PubMed ID: 5790872
    [No Abstract]   [Full Text] [Related]  

  • 37. [Further contribution to the study of the behavior of some enzymes (transaminase, lactic dehydrogenase and aldolase) in the blood during liver diseases of various types. Comparative study].
    SALONNA L; TRIGGIANI G; BASI R; CALPISTA F
    Prog Med (Napoli); 1961 May; 17():323-33. PubMed ID: 13745731
    [No Abstract]   [Full Text] [Related]  

  • 38. [Content of glycoproteids in the blood serum of the patients with chronic inflammatory diseases of the biliary tract and liver].
    Borevskaia BD; Gubergrits EA
    Vrach Delo; 1967 Feb; 2():14-6. PubMed ID: 5617012
    [No Abstract]   [Full Text] [Related]  

  • 39. [Serum transaminase and its significance in liver diseases].
    DANILA I; COMOROSAN S; MINCU I; ILIE E
    Med Interna (Bucur); 1960 Jan; 12():23-32. PubMed ID: 13814001
    [No Abstract]   [Full Text] [Related]  

  • 40. Determination of transaminase activity in dogs' serum and lymph after hepatic damage due to acute biliary obstruction.
    BRAUN P; PAPP M; HORVATH I
    Nature; 1959 Jan; 183(4653):48-9. PubMed ID: 13622686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.